Oxford BioMedica PLC - Asset Resilience Ratio

Latest as of June 2023: 0.01%

Oxford BioMedica PLC (OXB) has an Asset Resilience Ratio of 0.01% as of June 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See OXB current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

GBX31.00K

≈ $3.77 USD Cash + Short-term Investments

Total Assets

GBX401.06 Million

≈ $48.80K USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2003–2022)

This chart shows how Oxford BioMedica PLC's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Oxford BioMedica PLC (OXB) total assets.

Liquid Assets Composition Over Time

This chart breaks down Oxford BioMedica PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Oxford BioMedica PLC strategic investment ratio to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	GBX0.00	0%
Short-term Investments	GBX31.00K	0.01%
Total Liquid Assets	GBX31.00K	0.01%

Asset Resilience Insights

Limited Liquidity: Oxford BioMedica PLC maintains only 0.01% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Oxford BioMedica PLC Industry Peers by Asset Resilience Ratio

Compare Oxford BioMedica PLC's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Abivax SA PA:ABVX	Biotechnology	2.58%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Lifecome Biochemistry Co Ltd SHE:002868	Biotechnology	4.69%
Pulike Biological Engineering SHG:603566	Biotechnology	17.82%
Rocket Pharmaceuticals Inc NASDAQ:RCKT	Biotechnology	14.00%
NEWRON PHARMACEUT. EO-20 XETRA:NP5	Biotechnology	41.67%
Upstream Bio, Inc. NASDAQ:UPB	Biotechnology	64.70%

Annual Asset Resilience Ratio for Oxford BioMedica PLC (2003–2022)

The table below shows the annual Asset Resilience Ratio data for Oxford BioMedica PLC.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2022-12-31	0.00%	GBX23.00K ≈ $2.80	GBX460.18 Million ≈ $55.99K	-0.03pp
2021-12-31	0.03%	GBX74.00K ≈ $9.00	GBX237.23 Million ≈ $28.86K	-0.10pp
2020-12-31	0.13%	GBX239.00K ≈ $29.08	GBX183.93 Million ≈ $22.38K	-2.08pp
2019-12-31	2.21%	GBX2.72 Million ≈ $330.82	GBX122.93 Million ≈ $14.96K	-18.69pp
2012-12-31	20.90%	GBX5.11 Million ≈ $621.13	GBX24.42 Million ≈ $2.97K	-7.84pp
2011-12-31	28.74%	GBX7.50 Million ≈ $912.53	GBX26.09 Million ≈ $3.18K	+6.89pp
2010-12-31	21.85%	GBX5.60 Million ≈ $681.72	GBX25.64 Million ≈ $3.12K	-20.25pp
2009-12-31	42.09%	GBX18.50 Million ≈ $2.25K	GBX43.95 Million ≈ $5.35K	+10.21pp
2008-12-31	31.89%	GBX13.75 Million ≈ $1.67K	GBX43.12 Million ≈ $5.25K	-12.56pp
2007-12-31	44.45%	GBX27.18 Million ≈ $3.31K	GBX61.16 Million ≈ $7.44K	-13.24pp
2006-12-31	57.68%	GBX20.50 Million ≈ $2.49K	GBX35.54 Million ≈ $4.32K	+9.96pp
2005-12-31	47.72%	GBX23.50 Million ≈ $2.86K	GBX49.24 Million ≈ $5.99K	-13.50pp
2004-12-31	61.22%	GBX17.50 Million ≈ $2.13K	GBX28.58 Million ≈ $3.48K	-25.12pp
2003-12-31	86.34%	GBX31.70 Million ≈ $3.86K	GBX36.71 Million ≈ $4.47K	--

pp = percentage points

About Oxford BioMedica PLC

LSE:OXB UK Biotechnology

Market Cap

$7.24 Million

GBX59.53 Billion GBX

Market Cap Rank

#27921 Global

#404 in UK

Share Price

GBX493.00

Change (1 day)

+6.02%

52-Week Range

GBX424.00 - GBX913.00

All Time High

GBX1634.00